BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21472135)

  • 1. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
    Shahzad MM; Mangala LS; Han HD; Lu C; Bottsford-Miller J; Nishimura M; Mora EM; Lee JW; Stone RL; Pecot CV; Thanapprapasr D; Roh JW; Gaur P; Nair MP; Park YY; Sabnis N; Deavers MT; Lee JS; Ellis LM; Lopez-Berestein G; McConathy WJ; Prokai L; Lacko AG; Sood AK
    Neoplasia; 2011 Apr; 13(4):309-19. PubMed ID: 21472135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
    Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
    Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.
    Lin Q; Chen J; Jin H; Ng KK; Yang M; Cao W; Ding L; Zhang Z; Zheng G
    Nanomedicine (Lond); 2012 Dec; 7(12):1813-25. PubMed ID: 22830501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.
    Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J
    Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.
    Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M
    J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA.
    Rui M; Tang H; Li Y; Wei X; Xu Y
    Pharm Res; 2013 May; 30(5):1203-14. PubMed ID: 23242841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene silencing using RGD-labeled chitosan nanoparticles.
    Han HD; Mangala LS; Lee JW; Shahzad MM; Kim HS; Shen D; Nam EJ; Mora EM; Stone RL; Lu C; Lee SJ; Roh JW; Nick AM; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2010 Aug; 16(15):3910-22. PubMed ID: 20538762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
    Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
    Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
    Wang T; Subramanian C; Yu M; White PT; Kuai R; Sanchez J; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
    Surgery; 2019 Dec; 166(6):1168-1175. PubMed ID: 31371177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
    Sabnis S; Sabnis NA; Raut S; Lacko AG
    Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained small interfering RNA delivery by mesoporous silicon particles.
    Tanaka T; Mangala LS; Vivas-Mejia PE; Nieves-Alicea R; Mann AP; Mora E; Han HD; Shahzad MM; Liu X; Bhavane R; Gu J; Fakhoury JR; Chiappini C; Lu C; Matsuo K; Godin B; Stone RL; Nick AM; Lopez-Berestein G; Sood AK; Ferrari M
    Cancer Res; 2010 May; 70(9):3687-96. PubMed ID: 20430760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
    Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
    Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth.
    Crombez L; Morris MC; Dufort S; Aldrian-Herrada G; Nguyen Q; Mc Master G; Coll JL; Heitz F; Divita G
    Nucleic Acids Res; 2009 Aug; 37(14):4559-69. PubMed ID: 19483097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.